My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 138

    1.

    Toward an effective treatment of Alzheimer's disease.

    Blass JP, Weksler ME.

    Ann Intern Med. 1983 Feb;98(2):251-3. No abstract available. PMID: 6824261 [PubMed - indexed for MEDLINE]Related articles

    2.

    Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer's presenile dementia.

    Caltagirone C, Gainotti G, Masullo C.

    Int J Neurosci. 1982 May;16(3-4):247-9.PMID: 7169287 [PubMed - indexed for MEDLINE]Related articles

    3.

    Memory enhancement with oral physostigmine in Alzheimer's disease.

    [No authors listed]

    N Engl J Med. 1983 Mar 24;308(12):720-1. No abstract available. PMID: 6338388 [PubMed - indexed for MEDLINE]Related articles

    4.

    Oral physostigmine treatment of patients with Alzheimer's disease.

    Mohs RC, Davis BM, Johns CA, Mathé AA, Greenwald BS, Horvath TB, Davis KL.

    Am J Psychiatry. 1985 Jan;142(1):28-33.PMID: 3881051 [PubMed - indexed for MEDLINE]Related articles

    5.

    Physostigmine and its effect on six patients with dementia.

    Ashford JW, Soldinger S, Schaeffer J, Cochran L, Jarvik LF.

    Am J Psychiatry. 1981 Jun;138(6):829-30. No abstract available. PMID: 7246817 [PubMed - indexed for MEDLINE]Related articles

    6.

    Acute administration of individual optimal dose of physostigmine fails to improve mnesic performances in Alzheimers Presenile Dementia.

    Caltagirone C, Albanese A, Gainotti G, Masullo C.

    Int J Neurosci. 1983;18(1-2):143-7.PMID: 6840979 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cholinesterase inhibitors and opiate antagonists in patients with Alzheimer's disease.

    [No authors listed]

    N Engl J Med. 1983 Sep 1;309(9):555-6. No abstract available. PMID: 6877328 [PubMed - indexed for MEDLINE]Related articles

    8.

    A pilot study of clonidine plus physostigmine in Alzheimer's disease.

    Bierer LM, Aisen PS, Davidson M, Ryan TM, Schmeidler J, Davis KL.

    Dementia. 1994 Sep-Oct;5(5):243-6.PMID: 7951680 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hypertension associated with oral administration of physostigmine in a patient with Alzheimer's disease.

    Cain JW.

    Am J Psychiatry. 1986 Jul;143(7):910-2.PMID: 3717434 [PubMed - indexed for MEDLINE]Related articles

    10.

    Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies.

    Mohs RC, Davis BM, Greenwald BS, Mathé AA, Johns CA, Horvath TB, Davis KL.

    J Am Geriatr Soc. 1985 Nov;33(11):749-57.PMID: 2865282 [PubMed - indexed for MEDLINE]Related articles

    11.

    Oral physostigmine as treatment for dementia of the Alzheimer type: a long-term outpatient trial.

    Jenike MA, Albert MS, Baer L.

    Alzheimer Dis Assoc Disord. 1990 Winter;4(4):226-31.PMID: 2264980 [PubMed - indexed for MEDLINE]Related articles

    12.

    Physostigmine for Alzheimer's disease.

    Coelho F, Birks J.

    Cochrane Database Syst Rev. 2001;(2):CD001499. Review.PMID: 11405996 [PubMed - indexed for MEDLINE]Related articles

    13.

    Oral physostigmine and lecithin improve memory in Alzheimer's disease.

    Thal LJ, Fuld PA, Masur DM, Sharpless NS, Davies P.

    Psychopharmacol Bull. 1983;19(3):454-6. No abstract available. PMID: 6635124 [PubMed - indexed for MEDLINE]Related articles

    14.

    Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer type.

    Möller H-J, Hampel H, Hegerl U, Schmitt W, Walter K.

    Pharmacopsychiatry. 1999 May;32(3):99-106.PMID: 10463377 [PubMed - indexed for MEDLINE]Related articles

    15.

    Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease.

    Thal LJ, Masur DM, Sharpless NS, Fuld PA, Davies P.

    Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):627-36.PMID: 3797688 [PubMed - indexed for MEDLINE]Related articles

    16.

    Oral physostigmine in Alzheimer's disease.

    Davis KL, Mohs RC, Davis BM, Horvath TB, Greenwald BS, Rosen WG, Levy MI, Johns CA.

    Psychopharmacol Bull. 1983;19(3):451-3. No abstract available. PMID: 6635123 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term administration of oral physostigmine and lecithin improve memory in Alzheimer's disease.

    Levin HS, Peters BH.

    Ann Neurol. 1984 Feb;15(2):210. No abstract available. PMID: 6703661 [PubMed - indexed for MEDLINE]Related articles

    18.

    Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease.

    Jotkowitz S.

    Ann Neurol. 1983 Dec;14(6):690-1.PMID: 6360031 [PubMed - indexed for MEDLINE]Related articles

    19.

    Oral physostigmine and lecithin improve memory in Alzheimer disease.

    Thal LJ, Fuld PA, Masur DM, Sharpless NS.

    Ann Neurol. 1983 May;13(5):491-6.PMID: 6347034 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term outpatient treatment of senile dementia with oral physostigmine.

    Beller SA, Overall JE, Rhoades HM, Swann AC.

    J Clin Psychiatry. 1988 Oct;49(10):400-4.PMID: 3049561 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity